Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Human Mutation|May 10, 2005
Application of genomewide SNP arrays for detection of simulated susceptibility lociBettina Kulle, Markus Schirmer, Mohammad R Toliat, et al.
Scandinavian Journal of Gastroenterology|October 22, 2008
A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatmentAndrea Hille, Emine Schmidt-Giese, Robert M Hermann, et al.
Cells|June 12, 2019
Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic CancerRobert G Goetze, Soeren M Buchholz, Ning Ou, et al.
The Oncologist|May 12, 2011
Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancerHendrik A Wolff, Lena-Christin Conradi, Markus Schirmer, et al.
Scandinavian Journal of Gastroenterology|June 9, 2009
Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: results of a prospective studyAndrea Hille, Margret Rave-Fränk, Hans Christiansen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2009
KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapyJochen Gaedcke, Marian Grade, Klaus Jung, et al.
Radiation and Environmental Biophysics|November 19, 2010
Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell linesHendrik A Wolff, David Rolke, Margret Rave-Fränk, et al.
Genes, Chromosomes & Cancer|August 21, 2010
Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomasJochen Gaedcke, Marian Grade, Klaus Jung, et al.
Head & Neck|September 30, 2021
Human microRNA-182-5p and kinectin 1: Potential biomarkers for prognosis in oral squamous cell carcinomaMark Jakob, Lena M Mattes, Kristian Unger, et al.
Pharmacogenetics and Genomics|September 11, 2009
Effect of DNA repair host factors on temozolomide or dacarbazine melanoma treatment in CaucasiansLars Boeckmann, Markus Schirmer, Albert Rosenberger, et al.
Pageof 3